These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35143042)

  • 1. The earliest events in BRAF-mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways.
    Bleijenberg AG; IJspeert JE; Mulder JB; Drillenburg P; Stel HV; Lodder EM; Carvalho B; Jansen J; Meijer G; van Eeden S; Dekker E; van Noesel CJ
    J Pathol; 2022 Jun; 257(2):239-249. PubMed ID: 35143042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation.
    Yan HHN; Lai JCW; Ho SL; Leung WK; Law WL; Lee JFY; Chan AKW; Tsui WY; Chan ASY; Lee BCH; Yue SSK; Man AHY; Clevers H; Yuen ST; Leung SY
    Gut; 2017 Sep; 66(9):1645-1656. PubMed ID: 27329244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers.
    van Toledo DE; Bleijenberg AG; Venema A; de Wit MJ; van Eeden S; Meijer GA; Carvalho B; Dekker E; Henneman P; IJspeert JE; van Noesel CJ
    J Pathol Clin Res; 2024 Mar; 10(2):e348. PubMed ID: 38380944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
    J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLH1, BRAF and p53 - searching for significant markers to predict evolution towards adenocarcinoma in colonic sessile serrated lesions.
    Răduţă D; Dincă OM; Micu GV; Nichita L; Cioplea MD; Buşcă RM; Ardeleanu R; Mateescu RB; Benguş A; Zurac SA; Popp CG; Vlădan GC
    Rom J Morphol Embryol; 2021; 62(4):971-979. PubMed ID: 35673816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
    Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
    Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of sessile serrated adenoma/polyps with dysplasia/carcinoma based on immunohistochemistry, next-generation sequencing, and microsatellite instability testing: a case series study.
    Murakami T; Akazawa Y; Yatagai N; Hiromoto T; Sasahara N; Saito T; Sakamoto N; Nagahara A; Yao T
    Diagn Pathol; 2018 Nov; 13(1):88. PubMed ID: 30458818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea.
    Kim KM; Lee EJ; Ha S; Kang SY; Jang KT; Park CK; Kim JY; Kim YH; Chang DK; Odze RD
    Am J Surg Pathol; 2011 Sep; 35(9):1274-86. PubMed ID: 21836485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasia.
    Cappello F; Angerilli V; Dal Santo L; Munari G; Sabbadin M; Lo Mele M; Pennelli G; Luchini C; Parente P; Lazzi S; Fassan M
    Pathol Res Pract; 2022 Dec; 240():154214. PubMed ID: 36395596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
    Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
    Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas.
    Wang J; Li R; He Y; Yi Y; Wu H; Liang Z
    Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNT Pathway Gene Mutations Are Associated With the Presence of Dysplasia in Colorectal Sessile Serrated Adenoma/Polyps.
    Hashimoto T; Yamashita S; Yoshida H; Taniguchi H; Ushijima T; Yamada T; Saito Y; Ochiai A; Sekine S; Hiraoka N
    Am J Surg Pathol; 2017 Sep; 41(9):1188-1197. PubMed ID: 28614199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis.
    Bond CE; McKeone DM; Kalimutho M; Bettington ML; Pearson SA; Dumenil TD; Wockner LF; Burge M; Leggett BA; Whitehall VL
    Oncotarget; 2016 Oct; 7(43):70589-70600. PubMed ID: 27661107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
    Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
    BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis.
    Mezzapesa M; Losurdo G; Celiberto F; Rizzi S; d'Amati A; Piscitelli D; Ierardi E; Di Leo A
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome.
    Boparai KS; Dekker E; Polak MM; Musler AR; van Eeden S; van Noesel CJ
    Am J Pathol; 2011 Jun; 178(6):2700-7. PubMed ID: 21641392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
    J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of sessile serrated adenomas with dysplasia including intramucosal adenocarcinoma and colorectal carcinoma with a microsatellite instability phenotype.
    Sugai T; Uesugi N; Osakabe M; Yao T; Yanagawa N; Ajioka Y
    Hum Pathol; 2024 Mar; 145():9-15. PubMed ID: 38218351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor tyrosine kinase fusions act as a significant alternative driver of the serrated pathway in colorectal cancer development.
    Chan AW; Pan Y; Tong JH; Lung RW; Kwan JS; Chow C; Tin EK; Chung LY; Li H; Wong SS; Chau SL; Chan YY; Mak TW; Ng SS; To KF
    J Pathol; 2020 May; 251(1):74-86. PubMed ID: 32162306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.